View Older Stories View More Recent Stories
-
Intuitive Surgical is due to report on Tuesday. Here's what to watch out for.
-
Bernstein on Intuitive Surgical (ISRG): 'Upside to Q3 on Placements & Procedures'
-
Intuitive receives FDA clearance for AI-enhanced Ion lung biopsy system
-
Bernstein sees 'a strong buying opportunity' in this U.S. medical stock
-
Bernstein on Intuitive Surgical (ISRG): 'We See a Strong Buying Opportunity Here'
-
BofA Adjusts US 1 List
-
Needham: 'we believe that the Section 232 investigation creates a new overhang for the already beleaguered medical device sector'
-
Bernstein sees an 'enhanced buying opportunity' in this medical devices stock
-
Bernstein SocGen Group Reiterates Outperform Rating on Intuitive Surgical (ISRG)
-
Piper Sandler on Intuitive Surgical (ISRG): 'No Change To Our Positive View'
-
This MedTech stock is 'a strong buy under $500': Bernstein
-
Intuitive Surgical (ISRG) PT Raised to $615 at RBC Capital
-
Intuitive Surgical (ISRG) PT Raised at Bernstein; 'As "Broad Launch" Begins, We're Buyers'
-
Erste Group Downgrades Intuitive Surgical (ISRG) to Hold
-
Stifel Reiterates Buy Rating on Intuitive Surgical (ISRG)
-
Raymond James Reiterates Outperform Rating on Intuitive Surgical (ISRG)
-
Intuitive Surgical (ISRG) PT Raised to $571 at BTIG
-
Intuitive Surgical (ISRG) PT Raised to $595 at Piper Sandler
-
Intuitive Surgical (ISRG) PT Raised to $600 at Baird
-
After-hours movers: Texas Instruments, Intuitive Surgical, Enphase Energy, and more
-
Intuitive Surgical (ISRG) Tops Q2 EPS by 26c
-
Intuitive Surgical (ISRG) call put ratio 1 call to 1.6 puts into quarter results
-
Intuitive Surgical (ISRG) call put ratio 1 call to 2 puts into quarter results
-
Intuitive demonstrates transatlantic telesurgery with da Vinci 5 system
-
Intuitive receives FDA clearance for curved vessel sealer instrument
-
Leerink Partners reiterates positive view on Intuitive Surgical (ISRG) after securing DV5 CE Mark ahead of expectations
-
Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names
-
UBS identifies stock winners amid structural growth tailwinds
-
Bernstein on Intuitive Surgical (ISRG): 'We'd Buy the Dip Here'
-
Deutsche Bank Downgrades Intuitive Surgical (ISRG) to Sell
-
Erste Group Upgrades Intuitive Surgical (ISRG) to Buy
-
UFP Technologies (UFPT) Initiated at Strong Sell by Off Wall Street
-
Intuitive Surgical (ISRG) Announces CEO Transition Effective July 1, 2025
-
These 2 sectors are under-owned, Barclays says and advises where to invest
-
Wolfpack Research long Intuitive Surgical (ISRG) on UFPT's dependency
-
Intuitive Surgical (ISRG) Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection
-
Stifel Reiterates Buy Rating on Intuitive Surgical (ISRG)
-
Intuitive Surgical (ISRG) PT Lowered to $605 at RBC Capital
-
Intuitive Surgical (ISRG) PT Lowered to $590 at Truist Securities
-
Intuitive Surgical (ISRG) PT Lowered at Piper Sandler Despite 'Another Strong EPS Print'
-
Intuitive Surgical (ISRG) PT Lowered to $592 at Raymond James
-
Intuitive Surgical (ISRG) PT Lowered to $675, but Bernstein Reiterates Top Pick Status
-
Intuitive Surgical (ISRG) PT Lowered to $539 at Leerink Partners
-
Intuitive Surgical (ISRG) PT Lowered to $542 at BTIG
-
Intuitive Surgical (ISRG) PT Lowered to $530 at Jefferies
-
Intuitive Surgical (ISRG) PT Lowered to $470 at Evercore ISI
-
After-hours movers: Tesla, Oklo, Intuitive Surgical and more
-
Intuitive Surgical (ISRG) Tops Q1 EPS by 7c, Offers Outlook
-
Intuitive Surgical (ISRG) call put ratio 2.2 calls to 1 put into quarter results
-
Intuitive Surgical (ISRG) April 25 weekly 482.50 straddle priced into quarter results

